| [1] |
Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(7): 493-502. DOI: 10.1038/s41575-021-00457-x.
|
| [2] |
Dietrich CF, Averkiou M, Nielsen MB, et al. How to perform contrast-enhanced ultrasound (CEUS)[J]. Ultrasound Int Open, 2018, 4(1): E2-E15. DOI: 10.1055/s-0043-123931.
|
| [3] |
Zhang Q, Liang X, Zhang Y, et al. A review of contrast-enhanced ultrasound using SonoVue ® and Sonazoid™ in non-hepatic organs[J]. Eur J Radiol, 2023, 167: 111060. DOI: 10.1016/j.ejrad.2023.111060.
|
| [4] |
D'Onofrio M, Zamboni G, Faccioli N, et al. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging[J]. Abdom Imaging, 2007, 32(2): 171-181. DOI: 10.1007/s00261-006-9010-6.
|
| [5] |
Golea A, Badea R, Socaciu M, et al. Quantitative analysis of tissue perfusion using contrast-enhanced transabdominal ultrasound (CEUS) in the evaluation of the severity of acute pancreatitis[J]. Med Ultrason, 2010, 12(3): 198-204.
|
| [6] |
Wolske KM, Ponnatapura J, Kolokythas O, et al. Chronic pancreatitis or pancreatic tumor? A problem-solving approach[J]. Radiographics, 2019, 39(7): 1965-1982. DOI: 10.1148/rg.2019190011.
|
| [7] |
Liu J, Hu L, Zhou B, et al. Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis[J]. Transl Oncol, 2022, 18: 101357. DOI: 10.1016/j.tranon.2022.101357.
|
| [8] |
|
| [9] |
Yang J, Huang J, Zhang Y, et al. Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis[J]. Chin Med J, 2023, 136(17): 2028-2036. DOI: 10.1097/CM9.0000000000002300.
|
| [10] |
|
| [11] |
Wang Y, Li G, Yan K, et al. Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions[J]. Eur Radiol, 2022, 32(3): 2060-2069. DOI: 10.1007/s00330-021-08243-8.
|
| [12] |
Mukund A, Afridi MA, Karolak A, et al. Pancreatic ductal adenocarcinoma (PDAC): a review of recent advancements enabled by artificial intelligence[J]. Cancers, 2024, 16(12): 2240. DOI: 10.3390/cancers16122240.
|
| [13] |
Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention[J]. Gastroenterology, 2023, 164(5): 752-765. DOI: 10.1053/j.gastro.2023.02.012.
|
| [14] |
Jia WY, Gui Y, Chen XQ, et al. Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses[J]. Eur Radiol, 2022, 32(12): 8485-8496. DOI: 10.1007/s00330-022-08879-0.
|
| [15] |
Perik T, Alves N, Hermans JJ, et al. Automated quantitative analysis of CT perfusion to classify vascular phenotypes of pancreatic ductal adenocarcinoma[J]. Cancers, 2024, 16(3): 577. DOI: 10.3390/cancers16030577.
|
| [16] |
Zhou T, Tan L, Gui Y, et al. Correlation between enhancement patterns on transabdominal ultrasound and survival for pancreatic ductal adenocarcinoma[J]. Cancer Manag Res, 2021, 13: 6823-6832. DOI: 10.2147/ CMAR.S 307079.
|
| [17] |
|
| [18] |
Mohindroo C, McAllister F, De Jesus-Acosta A. Genetics of pancreatic neuroendocrine tumors[J]. Hematol Oncol Clin North Am, 2022, 36(5): 1033-1051. DOI: 10.1016/j.hoc.2022.07.005.
|
| [19] |
Dong Y, Yang DH, Tian XF, et al. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images[J]. Br J Radiol, 2023, 96(1149): 20220783. DOI: 10.1259/bjr.20220783.
|
| [20] |
Yang D, Wang D, Qiu Y, et al. Incidental nonfunctioning pancreatic neuroendocrine tumors: contrast enhanced ultrasound features in diagnosis1[J]. Clin Hemorheol Microcirc, 2022, 80(4): 343-352. DOI: 10.3233/ch-211269.
|
| [21] |
Jia WY, Gui Y, Chen XQ, et al. Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound[J]. Quant Imaging Med Surg, 2023, 13(6): 3902-3914. DOI: 10.21037/qims-22-1132.
|
| [22] |
Al Efishat M, Allen PJ. Therapeutic approach to cystic neoplasms of the pancreas[J]. Surg Oncol Clin N Am, 2016, 25(2): 351-361. DOI: 10.1016/j.soc.2015.11.006.
|
| [23] |
Yuan Z, Li J, Yang L, et al. The differential diagnosis of pancreatic cystic neoplasms with conventional ultrasound and contrast-enhanced ultrasound[J]. Quant Imaging Med Surg, 2024, 14(7): 4304-4318. DOI: 10.21037/qims-24-154.
|
| [24] |
院志强, 李加伍, 时莹瑜, 等. 常规超声及超声造影在胰腺囊肿和囊性肿瘤鉴别诊断中的研究[J]. 中国超声医学杂志, 2024, 40(9): 1031-1033.
|
| [25] |
|
| [26] |
|
| [27] |
Crinó SF, Brandolese A, Vieceli F, et al. Endoscopic ultrasound features associated with malignancy and aggressiveness of nonhypovascular solid pancreatic lesions: results from a prospective observational study[J]. Ultraschall Med, 2021, 42(2): 167-177. DOI: 10.1055/a-1014-2766.
|
| [28] |
Rimbaş M, Crino SF, Gasbarrini A, et al. EUS-guided fine-needle tissue acquisition for solid pancreatic lesions: Finally moving from fine-needle aspiration to fine-needle biopsy?[J]. Endosc Ultrasound, 2018, 7(3): 137-140. DOI: 10.4103/eus.eus_23_18.
|
| [29] |
Facciorusso A, Cotsoglou C, Chierici A, et al. Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration versus standard fine-needle aspiration in pancreatic masses: a propensity score analysis[J]. Diagnostics, 2020, 10(10): 792. DOI: 10.3390/diagnostics10100792.
|
| [30] |
Otsuka Y, Kamata K, Kudo M. Contrast-enhanced harmonic endoscopic ultrasound-guided puncture for the patients with pancreatic masses[J]. Diagnostics, 2023, 13(6): 1039. DOI: 10.3390/diagnostics13061039.
|
| [31] |
Seicean A, Jinga M. Harmonic contrast-enhanced endoscopic ultrasound fine-needle aspiration: fact or fiction?[J]. Endosc Ultrasound, 2017, 6(1): 31-36. DOI: 10.4103/2303-9027.196917.
|
| [32] |
Gincul R, Palazzo M, Pujol B, et al. Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial[J]. Endoscopy, 2014, 46(5): 373-379. DOI: 10.1055/s-0034-1364969.
|
| [33] |
|
| [34] |
|
| [35] |
Song Y, Lee SH. Recent treatment strategies for acute pancreatitis[J]. J Clin Med, 2024, 13(4): 978. DOI: 10.3390/jcm13040978.
|
| [36] |
Huang DY, Yusuf GT, Daneshi M, et al. Contrast-enhanced ultrasound (CEUS) in abdominal intervention[J]. Abdom Radiol, 2018, 43(4): 960-976. DOI: 10.1007/s00261-018-1473-8.
|
| [37] |
|
| [38] |
Catalano O, Lobianco R, Cusati B, et al. Contrast-enhanced sonography for diagnosis of ruptured abdominal aortic aneurysm[J]. AJR Am J Roentgenol, 2005, 184(2): 423-427. DOI: 10.2214/ajr.184.2.01840423.
|
| [39] |
Maruyama H, Sekimoto T, Yokosuka O. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience[J]. J Gastroenterol, 2016, 51(5): 421-433. DOI: 10.1007/s00535-015-1151-3.
|
| [40] |
Makino Y, Imai Y, Fukuda K, et al. Sonazoid-enhanced ultrasonography for the diagnosis of an intrapancreatic accessory spleen: a case report[J]. J Clin Ultrasound, 2011, 39(6): 344-347. DOI: 10.1002/jcu.20798.
|
| [41] |
Tatekawa Y. An intrapancreatic accessory spleen presenting as a rapidly growing pancreatic mass after splenectomy in a patient with hereditary spherocytosis: a case report and literature review[J]. J Surg Case Rep, 2018, 2018(2): rjy029. DOI: 10.1093/jscr/rjy029.
|
| [42] |
Park S, Je H, Jang S, et al. Comparison of sulfur hexafluoride microbubbles and perfluorobutane for performance of contrast-enhanced ultrasonography of the pancreas in dogs[J]. Am J Vet Res, 2021, 82(7): 538-545. DOI: 10.2460/ajvr.82.7.538.
|
| [43] |
Schultz CW, Ruiz de Garibay G, Langer A, et al. Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model[J]. Cancer Biol Ther, 2021, 22(3): 204-215. DOI: 10.1080/15384047.2021.1881026.
|